NCT06128252View on ClinicalTrials.gov

Clinical Study of Taurine Combined With Neoadjuvant Chemo-Immunotherapy for Treatment of Locally Advanced Gastric Cancer

NARecruitingINTERVENTIONAL
Enrollment

96

Participants

Timeline

Start Date

September 1, 2024

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions
Gastric Cancer
Interventions
DIETARY_SUPPLEMENT

Taurine

Taurine supplementation in tablets of 1.0 gram of taurine powder. Dosage: 3.0 gram/day. Frequency: 3 time/day.

BIOLOGICAL

Serplulimab

Serplulimab

DRUG

XELOX regimen

Oxaliplatin + capecitabine

DIETARY_SUPPLEMENT

Placebo

Taurine placebo in tablets of 1.0 gram of starch powder. Dosage: 3.0 gram/day. Frequency: 3 time/day.

Trial Locations (6)

710032

RECRUITING

Xi-jing Hospital, Xi'an

710038

RECRUITING

Tang-Du Hospital, Xi'an

710068

RECRUITING

Shaanxi Provincial People's Hospital, Xi'an

710100

RECRUITING

Xi 'an International Medical Center Hospital, Xi'an

Unknown

RECRUITING

The Second Affilated Hospital Of Xi'an Jiaotong University (Xibei Hospital), Xi'an

RECRUITING

Xi'an NO.3 hospital, Xi'an

All Listed Sponsors
lead

Tang-Du Hospital

OTHER